Post-acute Sequelae of Sars-cov-2 Infection
📧 Sign up to get email alerts when something new happens for Post-acute Sequelae of Sars-cov-2 Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Vagal Approaches on Long COVID-19 [NA]
Leidos Life Sciences completed a clinical trial evaluating vagal approaches for long COVID symptoms.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Study of LAU-7b for the Treatment of Long COVID in Adults [Phase 2, Phase 3]
Phase 2/3 clinical trial updates for LAU-7b in adults with post-acute sequelae of SARS-CoV-2 infection (Long COVID); results have been poste…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Immunoadsorption in Autoimmune Long COVID [Phase 2]
A Phase 2 clinical trial is evaluating immunoadsorption as a treatment for autoimmune Long COVID. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Supervised Computerized Active Program for People With Post-COVID Syndrome (SuperCAP Study) [NA]
This entry reports a completed clinical trial of a supervised computerized active program for Post-acute sequelae of SARS-CoV-2 infection. T…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Study to Investigate the Health Benefits of a Quercetin/Curcumin-Based Supplement for Mild to Moderate Long COVID-19 Symptoms [NA]
A completed clinical trial assessed the health benefits of a quercetin/curcumin-based supplement for mild-to-moderate Long COVID symptoms.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
The RECOVER trial examining the long-term effects of SARS-CoV-2 infection in adults has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms [Phase 2]
RECOVER-VITAL describes a Phase 2 platform protocol to evaluate the impact of antiviral therapies on long COVID symptoms, with results poste…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway [Phase 3]
Phase 3 trial evaluating Paxlovid for prevention of long COVID in the community in Norway is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19) [Phase 2]
Phase 2 clinical trial evaluating anti-SARS-CoV-2 monoclonal antibodies for Long COVID and post-acute sequelae of SARS-CoV-2 infection. Resu…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Tele-Rehabilitative Exercise Training Program in Nurses With Long COVID [NA]
A clinical trial evaluating a tele-rehabilitative exercise program for nurses with Long COVID has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: CORona (COVID-19) Follow Up Study: Epidemiology, Pathophysiology, Prediction, and Communication
A completed CORona follow-up clinical trial assessing epidemiology, pathophysiology, prediction, and communication related to COVID-19 and i…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: COPD Circuit Exercise [NA]
The document reports the completion of a COPD circuit exercise clinical trial sponsored by Texas A&M University, including participants with…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Visualizing Regional Lung Ventilation in Patients With Postacute-COVID-19
The completed trial visualized regional lung ventilation in patients with post-acute COVID-19 using electrical impedance tomography.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Use of a Cysteine-rich Whey Protein Isolate in Post COVID-19 Cognitive Impairment [NA]
This clinical trial update reports the completion of a study evaluating cysteine-rich whey protein isolate for post-COVID-19 cognitive impai…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Retraining of the Amygdala and Insula for the Treatment of Persistent Covid [NA]
A completed clinical trial evaluating brain retraining of the amygdala and insula for treating persistent COVID symptoms associated with Lon…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Immunoadsorption vs. Sham Treatment in Post COVID-19 Patients With Chronic Fatigue Syndrome [NA]
The clinical trial evaluating immunoadsorption versus sham treatment in post-COVID-19 patients with chronic fatigue syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Effects of Inspiratory Muscle Training After Covid-19 (ReCOV) [NA]
A completed clinical trial (NCT05024474) evaluated inspiratory muscle training as a post-COVID-19 intervention to improve respiratory functi…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Synbiotic Therapy for NP-PASC [NA]
A completed clinical trial sponsored by Columbia University evaluating a synbiotic therapy for post-acute sequelae of SARS-CoV-2 infection (…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Effects of Immulina TM Supplements With PASC Patients [Phase 3]
Phase 3 trial evaluating ImmulinaTM supplements in patients with Post-acute sequelae of SARS-CoV-2 infection has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome. [NA]
A clinical trial evaluating Endourage Formula C™ Oral Drops for post-acute COVID-19 syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Bevacizumab in Post-acute Sequelae of COVID-19 : Efficacy and Safety (Pilot Study) [Phase 2]
Pilot Phase 2 study evaluating bevacizumab for dyspnea in post-acute sequelae of SARS-CoV-2 infection (long COVID); the trial status is not …
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 [Phase 4]
A Phase 4 clinical trial evaluating Niagen (nicotinamide riboside) for recovery from persistent cognitive and physical symptoms after COVID-…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment [Phase 1]
A Phase 1 clinical trial assessing the Vielight Neuro RX Gamma device for post-COVID-19 cognitive impairment has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Cellular Senescence and COVID-19 Long-Hauler Syndrome
Mayo Clinic is conducting a clinical trial on cellular senescence and long-hauler COVID-19 (SARS-CoV-2 infection); the study (NCT04903132) i…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19 [Phase 3]
A Phase 3 study evaluating the efficacy and safety of Longidaza for residual lung changes after COVID-19 has completed.